175 related articles for article (PubMed ID: 38625840)
1. Nivolumab-Induced Cytokine Release Syndrome: A Case Report and Literature Review.
Ntwali F; Gilliaux Q; Honoré PM
Am J Case Rep; 2024 Apr; 25():e941835. PubMed ID: 38625840
[TBL] [Abstract][Full Text] [Related]
2. A case report of fulminant cytokine release syndrome complicated by dermatomyositis after the combination therapy with immune checkpoint inhibitors.
Ohira J; Kawamoto M; Sugino Y; Kohara N
Medicine (Baltimore); 2020 Apr; 99(15):e19741. PubMed ID: 32282733
[TBL] [Abstract][Full Text] [Related]
3. A case of cytokine release syndrome accompanied with COVID-19 infection during treatment with immune checkpoint inhibitors for non-small cell lung cancer.
Murata D; Azuma K; Tokisawa S; Tokito T; Hoshino T
Thorac Cancer; 2022 Oct; 13(20):2911-2914. PubMed ID: 36073307
[TBL] [Abstract][Full Text] [Related]
4. Delayed cytokine release syndrome after neoadjuvant nivolumab: a case report and literature review.
Ciner AT; Hochster HS; August DA; Carpizo DR; Spencer KR
Immunotherapy; 2021 Sep; 13(13):1071-1078. PubMed ID: 34287029
[TBL] [Abstract][Full Text] [Related]
5. Cytokine release syndrome complicated with severe rashes induced by nivolumab plus ipilimumab therapy in a patient with non-small cell lung cancer: A case report.
Tsutsui T; Hata K; Kawaguchi M; Kobayashi H; Kakizaki Y; Miyashita Y
Thorac Cancer; 2023 Aug; 14(23):2310-2313. PubMed ID: 37381088
[TBL] [Abstract][Full Text] [Related]
6. Severe Cytokine Release Syndrome and Immune Effector Cell-associated Neurotoxicity Syndrome in a Man Receiving Immune Checkpoint Inhibitors for Lung Cancer.
Tanaka T; Taoka M; Makimoto G; Ninomiya K; Higo H; Fujii M; Ichihara E; Ohashi K; Hotta K; Tabata M; Maeda Y
Intern Med; 2024 May; 63(9):1261-1267. PubMed ID: 37722894
[TBL] [Abstract][Full Text] [Related]
7. "Small" Intestinal Immunopathology Plays a "Big" Role in Lethal Cytokine Release Syndrome, and Its Modulation by Interferon-γ, IL-17A, and a Janus Kinase Inhibitor.
Kale SD; Mehrkens BN; Stegman MM; Kastelberg B; Carnes H; McNeill RJ; Rizzo A; Karyala SV; Coutermarsh-Ott S; Fretz JA; Sun Y; Koff JL; Rajagopalan G
Front Immunol; 2020; 11():1311. PubMed ID: 32676080
[TBL] [Abstract][Full Text] [Related]
8. Cytokine Release Syndrome in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Case Series of 25 Patients and Review of the Literature.
Tay SH; Toh MMX; Thian YL; Vellayappan BA; Fairhurst AM; Chan YH; Aminkeng F; Bharwani LD; Huang Y; Mak A; Wong ASC
Front Immunol; 2022; 13():807050. PubMed ID: 35154124
[TBL] [Abstract][Full Text] [Related]
9. IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome.
Kang S; Tanaka T; Inoue H; Ono C; Hashimoto S; Kioi Y; Matsumoto H; Matsuura H; Matsubara T; Shimizu K; Ogura H; Matsuura Y; Kishimoto T
Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22351-22356. PubMed ID: 32826331
[TBL] [Abstract][Full Text] [Related]
10. Plasma Exchange Can Be an Alternative Therapeutic Modality for Severe Cytokine Release Syndrome after Chimeric Antigen Receptor-T Cell Infusion: A Case Report.
Xiao X; He X; Li Q; Zhang H; Meng J; Jiang Y; Deng Q; Zhao M
Clin Cancer Res; 2019 Jan; 25(1):29-34. PubMed ID: 30322878
[TBL] [Abstract][Full Text] [Related]
11. Fatal cytokine-release syndrome in a patient receiving toripalimab: a case report.
Zhou Y; Zheng GH; Li N; Liu JJ; Wang XH; Li YF
Immunotherapy; 2023 Jun; 15(9):641-645. PubMed ID: 37139989
[TBL] [Abstract][Full Text] [Related]
12. Cytokine release syndrome in a patient with non-small cell lung cancer on ipilimumab and nivolumab maintenance therapy after vaccination with the mRNA-1273 vaccine: a case report.
Sumi T; Koshino Y; Michimata H; Nagayama D; Watanabe H; Yamada Y; Chiba H
Transl Lung Cancer Res; 2022 Sep; 11(9):1973-1976. PubMed ID: 36248324
[TBL] [Abstract][Full Text] [Related]
13. Pembrolizumab-induced cytokine release syndrome in a patient with metastatic lung adenocarcinoma: a case report.
Sackstein P; Zaemes J; Kim C
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34330765
[TBL] [Abstract][Full Text] [Related]
14. Severe cytokine release syndrome resulting in purpura fulminans despite successful response to nivolumab therapy in a patient with pleomorphic carcinoma of the lung: a case report.
Honjo O; Kubo T; Sugaya F; Nishizaka T; Kato K; Hirohashi Y; Takahashi H; Torigoe T
J Immunother Cancer; 2019 Apr; 7(1):97. PubMed ID: 30944043
[TBL] [Abstract][Full Text] [Related]
15. Cytokine Release Syndrome Induced by Immune-checkpoint Inhibitor Therapy for Non-small-cell Lung Cancer.
Yomota M; Mirokuji K; Sakaguchi M; Kitahara Y; Chin F; Setoguchi K; Hosomi Y
Intern Med; 2021 Nov; 60(21):3459-3462. PubMed ID: 33775995
[TBL] [Abstract][Full Text] [Related]
16. Systemic inflammatory syndromes as life-threatening side effects of immune checkpoint inhibitors: case report and systematic review of the literature.
Liu LL; Skribek M; Harmenberg U; Gerling M
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36878533
[TBL] [Abstract][Full Text] [Related]
17. Double systemic cytokine release syndrome following sequential infusion of anti-CD22 and anti-CD19 chimeric antigen receptor T cells after autologous hematopoietic stem cell transplantation for a central diffuse large B-cell lymphoma patient: A case report and literature review.
Zheng J; Xiao Y; Wu XQ; Xiao QZ; Feng C; Gao KB
Front Immunol; 2023; 14():1098815. PubMed ID: 36798130
[TBL] [Abstract][Full Text] [Related]
18. Severe cytokine release syndrome induced by immune checkpoint inhibitors in cancer patients - A case report and review of the literature.
Zhang Y; Wen X; OuYang Y; Hu Y; Fang X; Zhang J; Yuan Y
Heliyon; 2024 Jan; 10(2):e24380. PubMed ID: 38293388
[TBL] [Abstract][Full Text] [Related]
19. Tumor-related cytokine release syndrome in a treatment-naïve patient with lung adenocarcinoma: A case report.
Deng PB; Jiang J; Hu CP; Cao LM; Li M
World J Clin Cases; 2022 Feb; 10(5):1580-1585. PubMed ID: 35211595
[TBL] [Abstract][Full Text] [Related]
20. Case Report: A Case of Trimethoprim/Sulfamethoxazole-Triggered Hypotensive Shock: Cytokine Release Syndrome Related to Immune Checkpoint Inhibitors and Drug-Induced Hypersensitivity Syndrome.
Urasaki T; Ono M; Mochizuki T; Takeda K; Nishizawa A; Fukagawa E; Fujiwara M; Komai Y; Kitano S; Yuasa T; Yonese J; Takahashi S
Front Oncol; 2021; 11():681997. PubMed ID: 33996612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
